<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Kommentare zu: Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy.	</title>
	<atom:link href="http://www.gyn-weigert.at/adjuvant-endocrine-therapy-plus-zoledronic-acid-premenopausal-women-early-stage-breast-cancer-5-year-follow-abcsg-12-bone-mineral-density-substudy/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.gyn-weigert.at/adjuvant-endocrine-therapy-plus-zoledronic-acid-premenopausal-women-early-stage-breast-cancer-5-year-follow-abcsg-12-bone-mineral-density-substudy/</link>
	<description>Fachärztin für Gynäkologie und Geburtshilfe</description>
	<lastBuildDate>Mon, 29 Jun 2015 12:38:13 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.5.5</generator>
</channel>
</rss>
